This is a StreetInsider.com Premium Only Page

Mirati Therapeutics (MRTX) –

Feb 14, 2024 04:22 PM Form SC 13G Mirati Therapeutics, Filed by: BAKER BROS. ADVISORS LP

Feb 14, 2024 02:52 PM Form SC 13G/A Mirati Therapeutics, Filed by: ARMISTICE CAPITAL, LLC

Feb 14, 2024 09:13 AM Form SC 13G/A Mirati Therapeutics, Filed by: Avoro Capital Advisors LLC

Feb 14, 2024 07:13 AM Form SC 13G/A Mirati Therapeutics, Filed by: RTW INVESTMENTS, LP

Feb 13, 2024 05:15 PM Form SC 13G/A Mirati Therapeutics, Filed by: VANGUARD GROUP INC

Feb 9, 2024 12:30 PM Form SC 13G/A Mirati Therapeutics, Filed by: MORGAN STANLEY

Feb 9, 2024 12:21 PM Form SC 13G Mirati Therapeutics, Filed by: MORGAN STANLEY

Feb 8, 2024 10:15 AM Form SC 13G/A Mirati Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP

Feb 2, 2024 04:07 PM Form 15-12G Mirati Therapeutics,

Jan 31, 2024 02:09 PM Form SC 13G Mirati Therapeutics, Filed by: BlackRock Inc.

Jan 25, 2024 04:33 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Braslyn Ltd.

Jan 25, 2024 04:31 PM Form SC 13D/A Mirati Therapeutics, Filed by: Boxer Capital, LLC

Jan 25, 2024 06:05 AM Form EFFECT Mirati Therapeutics,

Jan 25, 2024 06:04 AM Form EFFECT Mirati Therapeutics,

Jan 25, 2024 06:04 AM Form EFFECT Mirati Therapeutics,

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Moriarty John B

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Johnson Craig A

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Hickey Benjamin

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: BAUM CHARLES M

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Gallagher Carol Giltner

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Cherrington Julie M

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Sharp Shalini

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: CARTER BRUCE L A

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Ondrey Aaron

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Martinez Maria E

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Sandler Alan B.

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Christensen Jamie

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Davis Aaron I.

Jan 23, 2024 08:38 PM Form 4 Mirati Therapeutics, For: Jan 23 Filed by: Hasnain Faheem

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:31 AM Form S-8 POS Mirati Therapeutics,

Jan 23, 2024 09:30 AM Form POSASR Mirati Therapeutics,

Jan 23, 2024 09:29 AM Form POS AM Mirati Therapeutics,

Jan 23, 2024 09:27 AM Form POS AM Mirati Therapeutics,

Jan 23, 2024 09:18 AM Form POS AM Mirati Therapeutics,

Jan 23, 2024 08:49 AM Form 8-K Mirati Therapeutics, For: Jan 23

Jan 23, 2024 08:39 AM Form 25-NSE Mirati Therapeutics, Filed by: Nasdaq Stock Market LLC

Jan 23, 2024 08:33 AM Bristol-Myers Squibb (BMY) Completes Acquisition of Mirati Therapeutics (MRTX)

Jan 18, 2024 04:46 PM Form 4 Mirati Therapeutics, For: Jan 16 Filed by: Hickey Benjamin

Jan 18, 2024 04:38 PM Form 4 Mirati Therapeutics, For: Jan 16 Filed by: Christensen Jamie

Jan 10, 2024 08:03 AM Mirati Therapeutics (MRTX) Announces European Commission Approves KRAZATI as Targeted Treatment Option for Patients with Advanced NSCLC with a KRASG12C Mutation